TiMELiNES
Everything has a timeline
TiMELiNES
January 2024
United States expands approval to transfusion-dependent beta thalassemia
U.S. authorization broadens the clinical scope of CRISPR-based therapy beyond sickle cell disease.
Context
Appears In
Authority
Sources
Taxonomy